Drug Type Small molecule drug |
Synonyms- |
Action modulators, agonists |
Mechanism SCNA modulators(Sodium voltage-gated channel alpha subunits modulators), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC13H23NO7S |
InChIKeyOVICLFZZVQVVFT-UHFFFAOYSA-N |
CAS Registry51022-70-9 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | Phase 3 | China | 20 Nov 2013 | |
| Asthma | Phase 3 | China | - | 20 Nov 2013 |
| Pulmonary Disease, Chronic Obstructive | Phase 2 | China | 09 Jan 2015 | |
| Acute Bronchitis | Phase 1 | China | 14 Jun 2014 | |
| Asthmatic bronchitis | Phase 1 | China | 14 Jun 2014 | |
| Bronchial Spasm | Phase 1 | China | 14 Jun 2014 | |
| Bronchitis, Chronic | Phase 1 | China | 14 Jun 2014 |





